Study Overview
Summarize objectives, hypothesis, study design, primary and secondary endpoints, estimated enrollment, and planned duration including brief justification for methodological choices and expected impact.
Use this Research Study Template to standardize protocol details, consent elements, and recordkeeping across studies. A consistent template reduces administrative errors, improves IRB review efficiency, and supports legally valid electronic records under ESIGN and UETA when signature intent and retention requirements are met.
Typical users include principal investigators, study coordinators, institutional review boards, and research compliance officers who manage study documentation.
The template works for academic, clinical, government, and commercial research teams when adapted to study risk, sponsor needs, and institutional policies.
Summarize objectives, hypothesis, study design, primary and secondary endpoints, estimated enrollment, and planned duration including brief justification for methodological choices and expected impact.
Define measurable inclusion and exclusion criteria, screening procedures, and enrollment caps to ensure reproducible participant selection and protect vulnerable populations.
Provide full informed consent text, assent forms where applicable, and clear risk/benefit language tailored to participant comprehension and IRB expectations.
Specify data collection instruments, storage location, de-identification methods, access controls, retention schedule, and data sharing or publication plans for audits and sponsor review.
Describe adverse event definitions, reporting timelines, DSMB or monitoring roles, stopping rules, and contact information for safety reporting to oversight bodies.
List IRB approvals, protocol numbers, reliance agreements, grant identifiers, and any state or federal authorizations required before enrollment begins; include submission and expiration dates.
| Field | Configuration |
|---|---|
| Signer Role | Assign PI, coordinator, sponsor; sequential routing |
| Authentication | Email link with optional SMS code; no account required |
| Auto Reminders | Enable daily reminders based on overdue status |
| Storage | Save signed PDFs to institutional cloud or SFTP |
For eSubmission, ensure your platform supports PDF and DOCX imports, SSO, conditional fields, and secure storage with AES-256 at rest and TLS 1.2/1.3 in transit.
Submit protocol before recruitment; expect 4–8 week review.
Prior to any study procedures for each participant.
Submit safety or progress reports per IRB schedule.
Agree on cutoff before analysis and publication.
Begin retention after study close-out and final report.
| signNow | DocuSign | Adobe Sign | PandaDoc | HelloSign | |
|---|---|---|---|---|---|
| Starting Price | $8/user/mo | $15/user/mo | $14/user/mo | $19/user/mo | $15/user/mo |
| Free Trial | 7-day free trial | Free trial available | Free trial available | Free trial available | Free trial available |
| Bulk Send | Yes | Yes | Yes | Yes | No |
| Audit Trail | Yes | Yes | Yes | Yes | Yes |
| HIPAA Compliant | Yes | Yes | Yes | No | No |
A clinical center standardized consent and recruitment documents across clinics to accelerate enrollment while maintaining compliance.
A small healthcare-adjacent provider processed patient forms across sites to save staff time and ensure consistent records.
Complete protocol and consent drafts for internal review and sponsor clearance.
Submit materials and respond to queries until formal approval is granted.
Open recruitment only after IRB approval and documentation are finalized.
Complete final reports, lock datasets, and begin archival retention schedule.
| Criteria | Electronic signature | Digital signature |
|---|---|---|
| Definition | any electronic mark | pki-based cryptographic signature |
| Legal status | accepted under esign/ueta | accepted and stronger technical non-repudiation |
| Non-repudiation | audit trail evidence | certificate-based cryptographic proof |
| Common use cases | consent forms, contracts | regulated submissions, high-assurance records |
The principal investigator is the primary signatory for scientific and operational commitments; their signature attests to protocol accuracy, responsibility for conduct, and oversight of participant protections in accordance with institutional policy and sponsor agreements.
An institutional official or delegated signatory signs for institutional acceptance, grants administrative permissions, and confirms resource commitments, study oversight arrangements, and agreement to sponsor or institutional terms.